Published in

American Chemical Society, Journal of Proteome Research, 4(12), p. 1847-1855, 2013

DOI: 10.1021/pr301190g

Links

Tools

Export citation

Search in Google Scholar

Imaging Mass Spectrometry Based Molecular Histology Differentiates Microscopically Identical and Heterogeneous Tumors.

Journal article published in 2013 by Emrys A. Jones, Nicole Schmitz, Cathelijn J. F. Waaijer, Christian K. Frese, Alexandra van Remoortere, René J. M. van Zeijl, Albert J. R. Heck ORCID, Pancras C. W. Hogendoorn, André M. Deelder, A. F. Maarten Altelaar ORCID, Judith V. M. G. Bovée, Liam A. McDonnell
This paper is available in a repository.
This paper is available in a repository.

Full text: Download

Green circle
Preprint: archiving allowed
  • Must obtain written permission from Editor
  • Must not violate ACS ethical Guidelines
Upload
Orange circle
Postprint: archiving restricted
  • Must obtain written permission from Editor
  • Must not violate ACS ethical Guidelines
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO

Abstract

Many tumors display significant cellular heterogeneity as well as molecular heterogeneity. Sensitive biomarkers that differentiate between diagnostically challenging tumors must contend with this heterogeneity. Mass spectrometry-based molecular histology of a patient series of heterogeneous, microscopically identical bone tumors highlighted the tumor cell types that could be characterized by a single profile and led to the identification of specific peptides that differentiate between the tumors.